Beam Therapeutics Inc.
BEAM
$16.76
-$0.23-1.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -387.34M | -376.74M | -143.59M | -143.01M | -134.74M |
| Total Depreciation and Amortization | 22.02M | 21.93M | 21.84M | 21.56M | 20.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.67M | 117.79M | 106.92M | 99.01M | 84.40M |
| Change in Net Operating Assets | -97.73M | -110.22M | -120.98M | -115.03M | -109.58M |
| Cash from Operations | -351.38M | -347.25M | -135.81M | -137.47M | -139.13M |
| Capital Expenditure | -9.57M | -8.95M | -9.57M | -15.94M | -30.15M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 122.96M | 193.95M | 166.39M | 137.83M | 23.08M |
| Cash from Investing | 113.38M | 185.01M | 156.83M | 121.90M | -7.08M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -308.00K | -485.00K | -1.12M | -1.32M | -1.83M |
| Issuance of Common Stock | 478.53M | 8.22M | 39.12M | 75.22M | 183.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -384.00K | -569.00K |
| Cash from Financing | 478.22M | 7.74M | 38.01M | 73.52M | 180.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 240.22M | -154.50M | 59.02M | 57.95M | 34.73M |